EsoBiotec

AstraZeneca to buy EsoBiotec for up to billion

AstraZeneca to buy EsoBiotec for up to $1 billion

By Ethan Caldwell
. March 17, 2025

AstraZeneca Plc, the UK drugmaker, agreed to buy the Belgian biotech EsoBiotec for as much as $1 billion to further boost its cancer capabilities. AstraZeneca

AstraZeneca to buy EsoBiotec for up to $1 billion

ED summons Lalu Prasad, kin for questioning in land-for-jobs case on Wednesday

Why ageing offshore oil and gas infrastructure is a costly problem

Trump pledges to boost ‘beautiful, clean coal’ to counter China’s energy edge

Moody’s places IndusInd Bank’s credit assessment on review for downgrade

BIGBLOC Construction arm acquires land parcel in MP to set up new facility

Down 2.5% in February so far, will Nifty 50 remain in red for 5th month? Technical experts suggest key levels to watch

Tencent changes the messaging on its AI strategy

Nisus Finance Services appoints Houlihan Lokey for GCC fund

BIGBLOC Construction arm acquires land parcel in MP to set up new facility

Derivatives accounting hit: IndusInd Bank’s stock loses about a quarter of its value in a single day

Tencent changes the messaging on its AI strategy

How Buffett prepped for the Trump onslaught

EsoBiotec

Business

Finances

Stock Market

Uncategorised